Marketing-authorisation holder
Nuvo Pharm
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| NUVIGIL100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 150MG | 200MG | 250MG | 50MG · Tablet | Armodafinil | United States | Marketed | 2007 |
| PROVIGIL100mg | 200mg · Tablet | Modafinil | United States | Marketed | 1998 |
| SULFASALAZINE500mg · Tablet, delayed release | Sulfasalazine | United States | Marketed | 2002 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 3 | 0 | CompaniesAll medicines |
Top substances
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Nuvo Pharm’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call